AU4908096A - Synthetic oligonucleotides which mimic telomeric sequences - Google Patents
Synthetic oligonucleotides which mimic telomeric sequencesInfo
- Publication number
- AU4908096A AU4908096A AU49080/96A AU4908096A AU4908096A AU 4908096 A AU4908096 A AU 4908096A AU 49080/96 A AU49080/96 A AU 49080/96A AU 4908096 A AU4908096 A AU 4908096A AU 4908096 A AU4908096 A AU 4908096A
- Authority
- AU
- Australia
- Prior art keywords
- mimic
- synthetic oligonucleotides
- telomeric sequences
- telomeric
- sequences
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/07—Nucleotidyltransferases (2.7.7)
- C12Y207/07049—RNA-directed DNA polymerase (2.7.7.49), i.e. telomerase or reverse-transcriptase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/13—Decoys
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/315—Phosphorothioates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US381097 | 1995-01-31 | ||
US08/381,097 US5643890A (en) | 1995-01-31 | 1995-01-31 | Synthetic oligonucleotides which mimic telomeric sequences for use in treatment of cancer and other diseases |
PCT/US1996/001206 WO1996023508A1 (en) | 1995-01-31 | 1996-01-30 | Synthetic oligonucleotides which mimic telomeric sequences |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4908096A true AU4908096A (en) | 1996-08-21 |
Family
ID=23503638
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU49080/96A Abandoned AU4908096A (en) | 1995-01-31 | 1996-01-30 | Synthetic oligonucleotides which mimic telomeric sequences |
Country Status (3)
Country | Link |
---|---|
US (1) | US5643890A (en) |
AU (1) | AU4908096A (en) |
WO (1) | WO1996023508A1 (en) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5489508A (en) * | 1992-05-13 | 1996-02-06 | University Of Texas System Board Of Regents | Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
US5958680A (en) * | 1994-07-07 | 1999-09-28 | Geron Corporation | Mammalian telomerase |
US7094766B1 (en) | 1995-06-06 | 2006-08-22 | Trustees Of Boston University | Use of locally applied DNA fragments |
US20030032610A1 (en) * | 1996-06-03 | 2003-02-13 | Gilchrest Barbara A. | Method to inhibit cell growth using oligonucleotides |
US6015710A (en) * | 1996-04-09 | 2000-01-18 | The University Of Texas System | Modulation of mammalian telomerase by peptide nucleic acids |
US6444650B1 (en) * | 1996-10-01 | 2002-09-03 | Geron Corporation | Antisense compositions for detecting and inhibiting telomerase reverse transcriptase |
DE19720151A1 (en) * | 1997-05-02 | 1998-11-05 | Max Delbrueck Centrum | Chimeric oligonucleotides and their use |
AU8492398A (en) * | 1997-07-17 | 1999-02-10 | Board Of Regents Of The University Of Nebraska, The | Telomere mimetic compounds and methods of use for same |
US6458559B1 (en) | 1998-04-22 | 2002-10-01 | Cornell Research Foundation, Inc. | Multivalent RNA aptamers and their expression in multicellular organisms |
US6017709A (en) * | 1998-04-29 | 2000-01-25 | University Of Houston | DNA replication templates stabilized by guanine quartets |
US8114850B2 (en) | 1999-04-08 | 2012-02-14 | Advanced Cancer Therapeutics, Llc | Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin |
US20080318890A1 (en) * | 1999-04-08 | 2008-12-25 | Antisoma Research Limited | Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin |
US7960540B2 (en) * | 1999-04-08 | 2011-06-14 | Advanced Cancer Therapeutics, Llc | Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin |
PT1181304E (en) * | 1999-04-08 | 2008-01-23 | Antisoma Res Ltd | Antiproliferative activity of g-righ oligonucleotides and method of using same to bind to nucleolin |
US20080318889A1 (en) * | 1999-04-08 | 2008-12-25 | Antisoma Research Limited | Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin |
KR20070112295A (en) * | 1999-09-10 | 2007-11-22 | 제론 코포레이션 | Oligonucleotide n3'→p5' thiophosphoramidates: their synthesis and use |
US6541202B1 (en) | 1999-10-13 | 2003-04-01 | Research & Development Institute, Inc. | Telomerase reverse transcriptase (TERT) genes from Candida albicans |
EP1237582B1 (en) | 1999-12-10 | 2011-09-14 | AntiCancer, Inc. | Methods for introducing genes into mammalian subjects |
AU2001268863B2 (en) * | 1999-12-13 | 2007-07-05 | Bioniche Life Sciences Inc. | Modulation of FAS and FASL expression |
US20020091095A1 (en) * | 1999-12-13 | 2002-07-11 | Phillips Nigel C. | Modulation of Fas and FasL expression |
CN100445380C (en) * | 1999-12-13 | 2008-12-24 | 拜昂尼科生命科学有限公司 | Therapeutically useful synthetic oligonucleotides |
AU2001251115A1 (en) * | 2000-03-31 | 2001-10-15 | Trustees Of Boston University | Use of locally applied dna fragments |
AU6886301A (en) * | 2000-08-29 | 2002-03-13 | Bioniche Life Sciences Inc | Modulation of fas and fasl expression |
US7563618B2 (en) * | 2001-03-23 | 2009-07-21 | Geron Corporation | Oligonucleotide conjugates |
AU2003244338C1 (en) * | 2001-03-23 | 2008-07-24 | Geron Corporation | Oligonucleotide conjugates |
EP1417307B1 (en) * | 2001-08-17 | 2009-04-15 | Bioniche Life Sciences Inc. | Oligonucleotide compositions and their use to induce apoptosis |
WO2004012669A2 (en) | 2002-08-01 | 2004-02-12 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Method of treating inflammatory arthropathies with suppressors of cpg oligonucleotides |
US7514414B2 (en) | 2001-09-24 | 2009-04-07 | The United States Of America As Represented By The Department Of Health And Human Services | Suppressors of CpG oligonucleotides and methods of use |
EP1432450B1 (en) | 2001-10-03 | 2005-12-28 | Bioniche Life Sciences Inc. | Therapeutically useful triethyleneglycol cholesteryl oligonucleotides |
US7435542B2 (en) * | 2002-06-24 | 2008-10-14 | Cornell Research Foundation, Inc. | Exhaustive selection of RNA aptamers against complex targets |
US8043622B2 (en) | 2002-10-08 | 2011-10-25 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Method of treating inflammatory lung disease with suppressors of CpG oligonucleotides |
US20060269924A1 (en) * | 2003-04-11 | 2006-11-30 | Trustees Of Boston University | Modulation of telomere-initiated cell signaling |
US20050070494A1 (en) * | 2003-05-14 | 2005-03-31 | Cutroneo Kenneth R. | Transforming growth factor-beta response element decoys and methods |
US20050282190A1 (en) * | 2004-04-09 | 2005-12-22 | Hua Shi | Modular design and construction of nucleic acid molecules, aptamer-derived nucleic acid constructs, RNA scaffolds, their expression, and methods of use |
US20090131351A1 (en) * | 2007-11-16 | 2009-05-21 | Antisoma Research Limited | Methods, compositions, and kits for modulating tumor cell proliferation |
WO2009143292A2 (en) * | 2008-05-21 | 2009-11-26 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Method of treating pneumoconiosis with oligodeoxynucleotides |
EP3329004B1 (en) | 2015-07-29 | 2020-01-15 | IFOM Fondazione Istituto Firc di Oncologia Molecolare | Therapeutic oligonucleotides |
EP3124609A1 (en) | 2015-07-29 | 2017-02-01 | IFOM Fondazione Istituto Firc di Oncologia Molecolare | Therapeutics oligonucleotides |
US10124062B2 (en) * | 2016-02-26 | 2018-11-13 | The United States Of America As Represented By The Department Of Veterans Affairs | Methods of treating, inhibiting and/or preventing an auditory impairment |
AU2017277647B2 (en) | 2016-06-08 | 2023-07-27 | President And Fellows Of Harvard College | Engineered viral vector reduces induction of inflammatory and immune responses |
AU2018364542A1 (en) | 2017-11-08 | 2020-04-16 | President And Fellows Of Harvard College | Compositions and methods for inhibiting viral vector-induced inflammatory responses |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5264423A (en) * | 1987-03-25 | 1993-11-23 | The United States Of America As Represented By The Department Of Health And Human Services | Inhibitors for replication of retroviruses and for the expression of oncogene products |
US5489508A (en) * | 1992-05-13 | 1996-02-06 | University Of Texas System Board Of Regents | Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
-
1995
- 1995-01-31 US US08/381,097 patent/US5643890A/en not_active Expired - Lifetime
-
1996
- 1996-01-30 WO PCT/US1996/001206 patent/WO1996023508A1/en active Application Filing
- 1996-01-30 AU AU49080/96A patent/AU4908096A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US5643890A (en) | 1997-07-01 |
WO1996023508A1 (en) | 1996-08-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4908096A (en) | Synthetic oligonucleotides which mimic telomeric sequences | |
GB2298653B (en) | Electroformed sheath | |
AU6625296A (en) | Dna constructs | |
AU5732298A (en) | Plant expansin promoter sequences | |
AU690034B2 (en) | Sequence controller | |
AU5441896A (en) | Cooperative oligonucleotides | |
AU5272996A (en) | Toothbrush | |
AU6621596A (en) | Toothbrush | |
AU2317095A (en) | Dna sequences | |
AU9580498A (en) | Expression control sequences | |
AU5645396A (en) | Ascomycins | |
AU3340797A (en) | Modified oligonucleotides | |
IL118306A0 (en) | Ataxia-telangiectasia gene | |
EP0832896A4 (en) | Phosphonate nucleotide derivatives | |
AU7007096A (en) | Toothbrushes | |
GB9502468D0 (en) | DNA Sequence | |
AU5990196A (en) | Multiple squib assembly | |
GB9526218D0 (en) | DNA Sequences | |
AU7130796A (en) | Toothbrush | |
GB9506051D0 (en) | Gene expression | |
AU6621996A (en) | Toothbrush | |
AU5654096A (en) | Antisense peptides | |
GB9526613D0 (en) | Sequence | |
AU2874697A (en) | Sequences coding for new bacteriocins | |
AU2696897A (en) | Modified oligonucleotides |